WindRose Health Investors Merges Clariness and SubjectWell to Create Global Patient Recruitment Platform
January 29, 2026
WindRose Health Investors led a transaction merging Clariness and SubjectWell into a single global patient recruitment platform that will operate under the Clariness name. The combined company brings broader geographic reach, technology and a large patient database to support clinical trials across 60+ countries and accelerate enrollment and retention for sponsors, CROs and sites.
- Buyers
- WindRose Health Investors
- Targets
- Clariness, SubjectWell
- Platforms
- Clariness
- Industry
- Healthcare Services
- Location
- Hamburg, Germany
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
WindRose Health Investors Makes Majority Growth Investment in SubjectWell
April 30, 2024
Healthcare Services
WindRose Health Investors completed a majority growth investment in SubjectWell, the patient-access marketplace that connects motivated patients to clinical trials and treatments. Terms were not disclosed; SubjectWell's management will remain in place and as active shareholders while WindRose provides growth capital to accelerate product development, machine learning and marketplace expansion.
-
WindRose Health Investors Invests in Stellus Rx
December 8, 2025
Healthcare Services
WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.
-
WindRose Health Investors Recapitalizes Veristat Group Inc.
April 7, 2021
Healthcare Services
WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.
-
WindRose Health Investors Recapitalizes RevHealth
July 27, 2022
Healthcare Services
WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.
-
WindRose Health Investors and Francisco Partners Invest in Avalon Healthcare Solutions
January 12, 2026
Healthcare Services
WindRose Health Investors has completed a growth investment in Avalon Healthcare Solutions, a Tampa-based diagnostic intelligence and lab benefits management platform. Existing investor Francisco Partners also made an additional investment to support Avalon’s continued product development and scaling for health plan clients.
-
WindRose Health Investors Makes Strategic Investment in CIVIE
January 13, 2025
Healthcare Services
WindRose Health Investors completed a strategic investment to form CIVIE, an AI-powered radiology platform built from Collaborative Imaging's technology. WindRose partnered with Collaborative Imaging's management team to acquire Ci's technology platform; the investment will support product development, sales and operations scale-up, and accelerated growth across radiology practices and hospital systems.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.